Journal
GYNECOLOGIC ONCOLOGY
Volume 130, Issue 3, Pages 636-641Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2013.05.023
Keywords
Trebananib; AMG 386; Edema; Ovarian cancer; Anti-angiogenic agent